Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for SBC Medical Group Holdings Inc. (SBC:NASDAQ), powered by AI.
SBC Medical Group Holdings Inc. is currently trading at $3.10. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for SBC Medical Group Holdings Inc. on Alpha Lenz.
SBC Medical Group Holdings Inc.'s P/E ratio is 6.3.
“SBC Medical Group Holdings Inc. trades at a P/E of 6.3 (undervalued) with strong ROE of 23.0%. Operating margin of 38.9% indicates strong profitability.”
Ask for details →SBC Medical Group Holdings Inc. is a dedicated entity within the healthcare sector, primarily focused on managing and developing medical facilities and services. The company specializes in providing comprehensive healthcare solutions that include the management of hospitals, outpatient centers, and specialized clinics. SBC Medical Group plays a pivotal role in enhancing healthcare access and quality by integrating advanced medical technologies and innovative patient care models. This entity serves various demographics, including urban and rural communities, ensuring that a broad spectrum of patients have access to necessary healthcare services. With a commitment to medical excellence and patient-centric care, SBC Medical Group supports healthcare professionals by offering state-of-the-art infrastructure and resources needed for efficient healthcare delivery. In the financial market, SBC operates as a significant contributor to the healthcare industry's growth narrative, attracting investors looking to participate in a stable and essential sector with long-term growth potential.
“SBC Medical Group Holdings Inc. trades at a P/E of 6.3 (undervalued) with strong ROE of 23.0%. Operating margin of 38.9% indicates strong profitability.”
Ask for details →SBC Medical Group Holdings Inc. (ticker: SBC) is a company listed on NASDAQ in the Industrials sector (Consulting Services). It has approximately 863 employees. Market cap is $319M.
The current price is $3.1 with a P/E ratio of 6.26x and P/B of 1.29x.
ROE is 23.00% and operating margin is 38.87%. Annual revenue is $174M.